- Home
- WINA vs GLPG Comparison
WINA vs GLPG Comparison
Compare WINA & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINA
- GLPG
- Stock Information
- Founded
- WINA 1988
- GLPG 1999
- Country
- WINA United States
- GLPG Belgium
- Employees
- WINA N/A
- GLPG N/A
- Industry
- WINA Other Specialty Stores
- GLPG Biotechnology: Pharmaceutical Preparations
- Sector
- WINA Consumer Discretionary
- GLPG Health Care
- Exchange
- WINA Nasdaq
- GLPG Nasdaq
- Market Cap
- WINA 1.5B
- GLPG 1.8B
- IPO Year
- WINA 1993
- GLPG 2005
- Fundamental
- Price
- WINA $382.11
- GLPG $27.87
- Analyst Decision
- WINA
- GLPG Sell
- Analyst Count
- WINA 0
- GLPG 4
- Target Price
- WINA N/A
- GLPG $25.33
- AVG Volume (30 Days)
- WINA 386.5K
- GLPG 254.2K
- Earning Date
- WINA 07-16-2025
- GLPG 07-23-2025
- Dividend Yield
- WINA 2.98%
- GLPG N/A
- EPS Growth
- WINA 2.14
- GLPG N/A
- EPS
- WINA 11.19
- GLPG N/A
- Revenue
- WINA $83,099,300.00
- GLPG $311,493,731.00
- Revenue This Year
- WINA $6.56
- GLPG $0.78
- Revenue Next Year
- WINA $3.57
- GLPG N/A
- P/E Ratio
- WINA $33.31
- GLPG N/A
- Revenue Growth
- WINA 0.33
- GLPG 18.32
- 52 Week Low
- WINA $295.79
- GLPG $22.36
- 52 Week High
- WINA $459.93
- GLPG $31.23
- Technical
- Relative Strength Index (RSI)
- WINA 31.96
- GLPG 51.86
- Support Level
- WINA $369.01
- GLPG $26.62
- Resistance Level
- WINA $459.93
- GLPG $29.28
- Average True Range (ATR)
- WINA 20.00
- GLPG 0.58
- MACD
- WINA -9.50
- GLPG -0.16
- Stochastic Oscillator
- WINA 0.00
- GLPG 54.51
About WINA Winmark Corporation
Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment including Franchising and one non-reportable segment Leasing. The franchising segment franchises value-oriented retail store that buys, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.